Although the class action suit was originally certified by a judge in Chicago, it was later decertified by the 7th District Appeals Court on the grounds that such a suit might bankrupt the industry. In 1996, negotiations led to a settlement offer between the companies and the hemophilia community. The companies offered $100,000 to each infected hemophiliac and each infected spouse, cohabitating partner, and child if, in exchange, the individuals would drop their lawsuits against the industry. Approximately 94 percent of respondents to the offer accepted the proposed settlement, although no payments had been made by the end of 1996. Because many persons with hemophilia have enormous medical bills from Medicaid, insurance companies, and hospitals, the settlement money may immediately be owed to others. Before any payments are made, this issue of payment to creditors will have to be dealt with. In the meantime, however, there are still approximately 500 individual cases proceeding forward against the manufacturers.